Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

1.

Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.

Niikura N, Liu J, Costelloe CM, Palla SL, Madewell JE, Hayashi N, Yu TK, Tokuda Y, Theriault RL, Hortobagyi GN, Ueno NT.

Oncologist. 2011;16(6):772-82. doi: 10.1634/theoncologist.2010-0378. Epub 2011 May 31.

PMID:
21632453
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.

Alberini JL, Lerebours F, Wartski M, Fourme E, Le Stanc E, Gontier E, Madar O, Cherel P, Pecking AP.

Cancer. 2009 Nov 1;115(21):5038-47. doi: 10.1002/cncr.24534.

PMID:
19645022
[PubMed - indexed for MEDLINE]
Free Article
3.

Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs.

Walker GV, Niikura N, Yang W, Rohren E, Valero V, Woodward WA, Alvarez RH, Lucci A Jr, Ueno NT, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1381-6. doi: 10.1016/j.ijrobp.2011.10.040. Epub 2012 Jan 26.

PMID:
22284689
[PubMed - indexed for MEDLINE]
4.

FDG-PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer.

Niikura N, Costelloe CM, Madewell JE, Hayashi N, Yu TK, Liu J, Palla SL, Tokuda Y, Theriault RL, Hortobagyi GN, Ueno NT.

Oncologist. 2011;16(8):1111-9. doi: 10.1634/theoncologist.2011-0089. Epub 2011 Jul 17.

PMID:
21765193
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer.

Mahner S, Schirrmacher S, Brenner W, Jenicke L, Habermann CR, Avril N, Dose-Schwarz J.

Ann Oncol. 2008 Jul;19(7):1249-54. doi: 10.1093/annonc/mdn057. Epub 2008 Mar 19.

PMID:
18356138
[PubMed - indexed for MEDLINE]
Free Article
6.

18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging.

Groheux D, Giacchetti S, Delord M, Hindié E, Vercellino L, Cuvier C, Toubert ME, Merlet P, Hennequin C, Espié M.

J Nucl Med. 2013 Jan;54(1):5-11. doi: 10.2967/jnumed.112.106864. Epub 2012 Dec 4.

PMID:
23213197
[PubMed - indexed for MEDLINE]
Free Article
7.

Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.

Riegger C, Herrmann J, Nagarajah J, Hecktor J, Kuemmel S, Otterbach F, Hahn S, Bockisch A, Lauenstein T, Antoch G, Heusner TA.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):852-63. doi: 10.1007/s00259-012-2077-0. Epub 2012 Mar 6.

PMID:
22392069
[PubMed - indexed for MEDLINE]
8.

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.

Fuster D, Duch J, Paredes P, Velasco M, Muñoz M, Santamaría G, Fontanillas M, Pons F.

J Clin Oncol. 2008 Oct 10;26(29):4746-51. doi: 10.1200/JCO.2008.17.1496. Epub 2008 Aug 11.

PMID:
18695254
[PubMed - indexed for MEDLINE]
Free Article
9.

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M.

J Clin Oncol. 2009 Jul 10;27(20):3303-11. doi: 10.1200/JCO.2008.19.4423. Epub 2009 May 18.

PMID:
19451443
[PubMed - indexed for MEDLINE]
Free Article
10.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
[PubMed - indexed for MEDLINE]
11.

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.

Koolen BB, Vrancken Peeters MJ, Aukema TS, Vogel WV, Oldenburg HS, van der Hage JA, Hoefnagel CA, Stokkel MP, Loo CE, Rodenhuis S, Rutgers EJ, Valdés Olmos RA.

Breast Cancer Res Treat. 2012 Jan;131(1):117-26. doi: 10.1007/s10549-011-1767-9. Epub 2011 Sep 21.

PMID:
21935602
[PubMed - indexed for MEDLINE]
12.

The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.

Mittal BR, Manohar K, Kashyap R, Bhattacharya A, Singh B, Singh G.

Hell J Nucl Med. 2011 May-Aug;14(2):135-9.

PMID:
21761015
[PubMed - indexed for MEDLINE]
13.

Role of FDG-PET in the assessment of survival prognosis in melanoma.

Pleiss C, Risse JH, Biersack HJ, Bender H.

Cancer Biother Radiopharm. 2007 Dec;22(6):740-7.

PMID:
18158764
[PubMed - indexed for MEDLINE]
14.

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.

Aukema TS, Rutgers EJ, Vogel WV, Teertstra HJ, Oldenburg HS, Vrancken Peeters MT, Wesseling J, Russell NS, Valdés Olmos RA.

Eur J Surg Oncol. 2010 Apr;36(4):387-92. doi: 10.1016/j.ejso.2009.11.009. Epub 2009 Dec 3.

PMID:
19962268
[PubMed - indexed for MEDLINE]
15.

Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.

Groheux D, Moretti JL, Baillet G, Espie M, Giacchetti S, Hindie E, Hennequin C, Vilcoq JR, Cuvier C, Toubert ME, Filmont JE, Sarandi F, Misset JL.

Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):695-704. doi: 10.1016/j.ijrobp.2008.02.056. Epub 2008 Apr 23.

PMID:
18436392
[PubMed - indexed for MEDLINE]
16.

18-Fluorodeoxyglucose-positron emission tomography in inflammatory breast cancer.

Baslaim MM, Bakheet SM, Bakheet R, Ezzat A, El-Foudeh M, Tulbah A.

World J Surg. 2003 Oct;27(10):1099-104. Epub 2003 Aug 18.

PMID:
12917770
[PubMed - indexed for MEDLINE]
17.

Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.

Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.

Oral Oncol. 2007 Oct;43(9):887-93. Epub 2007 Jan 4.

PMID:
17207656
[PubMed - indexed for MEDLINE]
18.

[Detection of metastases in breast cancer patients: comparison of FDG PET with chest X-ray, bone scintigraphy and ultrasound of the abdomen].

Dose-Schwarz J, Mahner S, Schirrmacher S, Jenicke L, Müller V, Habermann CR, Brenner W.

Nuklearmedizin. 2008;47(3):97-103. German.

PMID:
18493688
[PubMed - indexed for MEDLINE]
19.

Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, Yamamoto M, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

Jpn J Clin Oncol. 2008 Apr;38(4):250-8. doi: 10.1093/jjco/hyn019.

PMID:
18407934
[PubMed - indexed for MEDLINE]
Free Article
20.

Utility of 18F-fluoro-deoxyglucose emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in combination with ultrasonography for axillary staging in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, Kondo T, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

BMC Cancer. 2008 Jun 9;8:165. doi: 10.1186/1471-2407-8-165.

PMID:
18541009
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk